BioVie
BIVI
37 hedge funds and large institutions have $968K invested in BioVie in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 9 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
0.11% more ownership
Funds ownership: 0.43% → 0.54% (+0.11%)
10% less funds holding
Funds holding: 41 → 37 (-4)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
36% less capital invested
Capital invested by funds: $1.52M → $968K (-$550K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$714K |
| 2 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$63.9K |
| 3 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
+$25.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$23.4K |
| 5 |
Cerity Partners
New York
|
+$19.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$245K |
| 2 |
DWM
Drive Wealth Management
Lehi,
Utah
|
-$71.9K |
| 3 |
PWM
Prosperity Wealth Management
San Ramon,
California
|
-$63.3K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$59.2K |
| 5 |
ZIG
Zullo Investment Group
Scranton,
Pennsylvania
|
-$46K |
BIVI Hedge Fund Activity: Q1 2025 in Review
37 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q1 2025, worth a combined $968K — down 36% from $1.52M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BIVI and 6 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 10 added.
The largest buyer was Vanguard Group, adding an estimated $714K. The largest seller was Millennium Management, exiting entirely with an estimated $245K sold.
- 37 institutional investors held BioVie (BIVI) as of Q1 2025, down from 41 in Q4 2024.
- Funds reported $968K of BioVie stock for Q1 2025, down 36% quarter-over-quarter.
- 6 funds opened new BioVie positions in Q1 2025 and 9 closed out, a net change of -3 holders.
- The largest BioVie buyer in Q1 2025 was Vanguard Group, an estimated $714K added.
- The largest BioVie seller in Q1 2025 was Millennium Management, an estimated $245K sold.
Based on aggregated 13F filings for Q1 2025.